Related Experiment Video
Updated: Aug 6, 2026
06:48
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Cardiomyopathy in congenital complete lipodystrophy
S Bhayana1, V M Siu, G I Joubert
1John P. Robarts Research Institute, London, Ontario, Canada.
Clinical Genetics
|May 29, 2002
Summary
Congenital lipodystrophy can be associated with cardiac issues. A patient with Berardinelli-Seip congenital complete lipodystrophy due to a BSCL2 mutation also developed hypertrophic cardiomyopathy, highlighting a potential genetic link.
Area of Science:
- Genetics
- Cardiology
- Endocrinology
Background:
- Congenital lipodystrophy syndromes are rare genetic disorders characterized by a near-complete absence of adipose tissue.
- Molecular genetic studies suggest a link between lipodystrophy and cardiac disorders, with mutations in the LMNA gene causing either lipodystrophy or cardiomyopathy.
Observation:
- A 10-year-old female with Berardinelli-Seip congenital complete lipodystrophy (BSCL2 mutation) presented with typical lipodystrophy features.
- The patient was diagnosed with hypertrophic cardiomyopathy in her first year of life, with disease progression monitored via non-invasive imaging.
Findings:
- The study describes a case of Berardinelli-Seip congenital complete lipodystrophy associated with hypertrophic cardiomyopathy.
- The underlying mechanism for cardiomyopathy in this condition remains unclear, with possibilities including direct gene effects or secondary hyperinsulinemia.
Implications:
- This case underscores the complex relationship between genetic mutations causing lipodystrophy and the development of cardiac abnormalities.
- Further research is needed to elucidate the precise mechanisms linking lipodystrophy genes to cardiomyopathy and to understand the variability in clinical presentation.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...